The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AGORA INC | ADS | 00851L103 | 183 | 11,268 | SH | SOLE | 183 | 0 | 0 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 2,397 | 31,637 | SH | SOLE | 2,397 | 0 | 0 | ||
EDITAS MEDICINE INC | COM | 28106W103 | 12,834 | 483,380 | SH | SOLE | 12,834 | 0 | 0 | ||
COINBASE GLOBAL INC | COM CL A | 19260Q107 | 21,595 | 85,570 | SH | SOLE | 21,595 | 0 | 0 | ||
COUPA SOFTWARE INC | COM | 22266L106 | 24,093 | 152,440 | SH | SOLE | 24,093 | 0 | 0 | ||
LITHIUM AMERS CORP NEW | COM NEW | 53680Q207 | 53,749 | 1,845,765 | SH | SOLE | 53,749 | 0 | 0 | ||
TESLA INC | COM | 88160R101 | 67,629 | 63,995 | SH | SOLE | 67,629 | 0 | 0 | ||
ALBEMARLE CORP | COM | 012653101 | 93,239 | 398,849 | SH | SOLE | 93,239 | 0 | 0 | ||
ASANA INC | CL A | 04342Y104 | 97,555 | 1,308,584 | SH | SOLE | 97,555 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 117,147 | 990,752 | SH | SOLE | 117,147 | 0 | 0 | ||
TELADOC HEALTH INC | COM | 87918A105 | 198,626 | 2,163,209 | SH | SOLE | 198,626 | 0 | 0 | ||
SEA LTD | SPONSORED ADS | 81141R100 | 335,565 | 1,499,999 | SH | SOLE | 335,565 | 0 | 0 | ||
DOORDASH INC | CL A | 25809K105 | 512,075 | 3,439,050 | SH | SOLE | 512,075 | 0 | 0 | ||
SHOPIFY INC | CL A | 82509L107 | 550,674 | 399,795 | SH | SOLE | 550,674 | 0 | 0 | ||
ROBLOX CORP | CL A | 771049103 | 632,089 | 6,127,271 | SH | SOLE | 632,089 | 0 | 0 |